NEW YORK (AP) -- Luminex Corp., which makes testing systems for biotechnology companies, said Tuesday it extended a marketing agreement with Bio-Rad Laboratories Inc.
The companies say Bio-Rad will sell and distribute Luminex's products through 2023. Bio-Rad will have worldwide sales and distribution rights for Luminex's xMap laboratory testing systems, including its Magpix system.
Other terms of the agreement weren't disclosed.
Bio-Rad is based in Hercules, Calif., and it makes instruments used in bio-medical research.
Bio-Rad stock jumped $11.33, or 11 percent, to $114.25 on Tuesday, shares of Luminex, which is based in Austin, Texas, picked up 10 cents to $23.66.